Pre-Clinical Equipment With Proprietary Technologies For Approach Towards COVID-19 Applications
2 equipment items found
-
Manufactured by Gritstone Biobased in USA
Gritstone is developing a second generation vaccine against SARS-CoV-2, the virus that causes COVID-19, with potential for both prolonged protection and potency, including against emerging Spike mutant forms of ...
-
Manufactured by Gritstone Biobased in USA
The first pillar of our immunotherapy is our understanding of antigens and neoantigens, and specifically which ones will be transcribed, translated, processed and presented on a cell surface by Human leukocyte antigen (HLA) molecules; and therefore will be visible to T cells. We accomplish this through the use of Gritstone EDGETM, our proprietary machine learning-based ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you